Lawrence M. Blatt

7.0k total citations
140 papers, 4.9k citations indexed

About

Lawrence M. Blatt is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Lawrence M. Blatt has authored 140 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Epidemiology, 67 papers in Hepatology and 26 papers in Infectious Diseases. Recurrent topics in Lawrence M. Blatt's work include Hepatitis C virus research (62 papers), Hepatitis B Virus Studies (51 papers) and Liver Disease Diagnosis and Treatment (33 papers). Lawrence M. Blatt is often cited by papers focused on Hepatitis C virus research (62 papers), Hepatitis B Virus Studies (51 papers) and Liver Disease Diagnosis and Treatment (33 papers). Lawrence M. Blatt collaborates with scholars based in United States, Belgium and France. Lawrence M. Blatt's co-authors include Myron J. Tong, Andrew Conrad, Milton W. Taylor, John G. McHutchison, Keyur Patel, Nassim Usman, Susan Blakeley Klein, Paul J. Pockros, Robert W. Sidwell and Janice M. Davis and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Lawrence M. Blatt

131 papers receiving 4.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lawrence M. Blatt United States	37	2.6k	2.3k	1.1k	908	730	140	4.9k
Johnson Y. N. Lau United States	38	3.4k 1.3×	3.9k 1.7×	1.1k 1.0×	1.0k 1.1×	329 0.5×	96	5.7k
Tatsuo Kanda Japan	43	3.4k 1.3×	3.4k 1.5×	676 0.6×	1.8k 2.0×	642 0.9×	359	7.3k
Robert S. Kauffman United States	32	3.3k 1.3×	3.5k 1.6×	1.5k 1.5×	1.1k 1.2×	579 0.8×	58	6.3k
Shiu‐Wan Chan United Kingdom	20	2.2k 0.9×	2.4k 1.1×	424 0.4×	939 1.0×	307 0.4×	37	3.9k
Junqi Niu China	40	2.9k 1.1×	2.5k 1.1×	699 0.7×	1.5k 1.7×	993 1.4×	267	5.7k
Lorenz Theilmann Germany	29	3.2k 1.3×	4.0k 1.8×	633 0.6×	813 0.9×	303 0.4×	130	5.6k
Takeshi Tanaka Japan	33	2.4k 1.0×	2.6k 1.2×	615 0.6×	499 0.5×	259 0.4×	100	4.3k
Robert Flisiak Poland	41	5.4k 2.1×	5.4k 2.4×	1.5k 1.4×	828 0.9×	514 0.7×	364	7.8k
Zania Stamataki United Kingdom	26	1.6k 0.6×	1.7k 0.7×	654 0.6×	515 0.6×	596 0.8×	63	3.4k
Hong Ren China	38	2.2k 0.9×	1.8k 0.8×	290 0.3×	1.4k 1.5×	844 1.2×	310	5.4k

Countries citing papers authored by Lawrence M. Blatt

Since Specialization

Citations

This map shows the geographic impact of Lawrence M. Blatt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence M. Blatt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence M. Blatt more than expected).

Fields of papers citing papers by Lawrence M. Blatt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence M. Blatt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence M. Blatt. The network helps show where Lawrence M. Blatt may publish in the future.

Co-authorship network of co-authors of Lawrence M. Blatt

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence M. Blatt. A scholar is included among the top collaborators of Lawrence M. Blatt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence M. Blatt. Lawrence M. Blatt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gane, Edward, Christian Schwabe, Min Wu, et al.. (2025). A Phase 1 study of the safety, tolerability, and pharmacokinetics of ALG-000184 (pevifoscorvir sodium), a novel Class E capsid assembly modulator, in healthy participants. Antiviral Therapy. 30(6). 232118715–232118715.

Vanrusselt, Hannah, Dieudonné Buh Kum, Valério Taverniti, et al.. (2023). Novel non-HAP class A HBV capsid assembly modulators have distinct in vitro and in vivo profiles. Journal of Virology. 97(10). e0072223–e0072223. 4 indexed citations

Chumakov, Konstantin, Michael S. Avidan, Christine Stabell Benn, et al.. (2021). Old vaccines for new infections: Exploiting innate immunity to control COVID-19 and prevent future pandemics. Proceedings of the National Academy of Sciences. 118(21). 64 indexed citations

Zhang, Qingling, Sandrine Vendeville, V. N. Serebryany, et al.. (2020). ALG-000184, a prodrug of capsid assembly modulator ALG-001075, demonstrates best-in-class preclinical characteristics for the treatment of chronic hepatitis B. Journal of Hepatology. 73. S880–S881. 4 indexed citations

Zhang, Qingling, Justin G. Julander, Antitsa Stoycheva, et al.. (2015). Development of a Hyperglycosylated IFN Alfacon-1 (CIFN): Toward Bimonthly or Monthly Dosing for Antiviral Therapies. Journal of Interferon & Cytokine Research. 35(8). 621–633. 2 indexed citations

Forestier, Nicole, Dominique Larrey, Dominique Guyader, et al.. (2010). Treatment of chronic hepatitis C patients with the NS3/4A protease inhibitor danoprevir (ITMN-191/RG7227) leads to robust reductions in viral RNA: A phase 1b multiple ascending dose study. Journal of Hepatology. 54(6). 1130–1136. 48 indexed citations

Wang, Tony, Lawrence M. Blatt, & Scott D. Seiwert. (2006). Immunomodulatory Activities of IFN-γ1b in Combination with Type I IFN: Implications for the Use of IFN-γ1b in the Treatment of Chronic HCV Infections. Journal of Interferon & Cytokine Research. 26(7). 473–483. 8 indexed citations

Edenberg, Howard J., Matthew A. Stephens, Jeanette N. McClintick, et al.. (2006). Differential Gene Induction by Type I and Type II Interferons and Their Combination. Journal of Interferon & Cytokine Research. 26(7). 462–472. 87 indexed citations

Patel, Keyur, Suzanne Norris, Lauralynn K. Lebeck, et al.. (2006). HLA class I allelic diversity and progression of fibrosis in patients with chronic hepatitis C. Hepatology. 43(2). 241–249. 34 indexed citations

10.

Phillips, Roderick J., Tony Wang, Lawrence M. Blatt, & Scott D. Seiwert. (2005). PIRFENIDONE MEDIATES DIFFERENTIAL EFFECTS ON LIPOPOLYSACCHARIDE-INDUCED CYTOKINE EXPRESSION IN HUMAN PERIPHERAL MONONUCLEAR CELLS. CHEST Journal. 128(4). 169S–169S. 5 indexed citations

11.

Tan, Hua, Jin Tae Hong, W. M. Grosse, et al.. (2005). Global Transcriptional Profiling Demonstrates the Combination of Type I and Type II Interferon Enhances Antiviral and Immune Responses at Clinically Relevant Doses. Journal of Interferon & Cytokine Research. 25(10). 632–649. 29 indexed citations

12.

Özeş, Osman N., et al.. (2004). Effect of Interferon-gamma 1b in Cellular Models of Lung Fibrosis: Implications for the Treatment of Idiopathic Pulmonary Fibrosis (IPF). CHEST Journal. 126(4). 889S–889S. 1 indexed citations

13.

Pianko, Stephen, John G. McHutchison, Stuart C. Gordon, et al.. (2002). Hepatic Iron Concentration Does Not Influence Response to Therapy with Interferon Plus Ribavirin in Chronic HCV Infection. Journal of Interferon & Cytokine Research. 22(4). 483–489. 21 indexed citations

14.

Cotler, Scott J., K. Rajender Reddy, Anguo Liu, et al.. (2001). An Analysis of Acute Changes in Interleukin-6 Levels After Treatment of Hepatitis C with Consensus Interferon. Journal of Interferon & Cytokine Research. 21(12). 1011–1019. 24 indexed citations

15.

Dhib‐Jalbut, Suhayl, Hong Jiang, Qian Xia, et al.. (1996). Comparative Effects of Interferon-Consensus 1, Interferon-α _2a , and Interferon-/β _lb on HLA Expression and Lymphoproliferation: A Preclinical Model for Treatment of Multiple Sclerosis. Journal of Interferon & Cytokine Research. 16(3). 195–200. 8 indexed citations

16.

Blatt, Lawrence M., et al.. (1995). Detection of inducible nitric oxide synthase in the liver infected with hepatitis C virus using non-radioactive in situ hybridisation. Gastroenterology. 108(4). A1188–A1188. 1 indexed citations

17.

Huang, Yanling, Lawrence M. Blatt, & Milton W. Taylor. (1995). Type 1 Interferon as an Antiinflammatory Agent: Inhibition of Lipopolysaccharide-Induced Interleukin-lβ and Induction of Interleukin-1 Receptor Antagonist. Journal of Interferon & Cytokine Research. 15(4). 317–321. 51 indexed citations

18.

Klein, Stefanie, Lawrence M. Blatt, & Michael W. Taylor. (1993). Consensus Interferon Induces Peak mRNA Accumulation at Lower Concentrations Than Interferon-α2a. Journal of Interferon Research. 13(5). 341–347. 18 indexed citations

19.

Özeş, Osman N., et al.. (1992). A Comparison of Interferon-Con1 with Natural Recombinant Interferons-α: Antiviral, Antiproliferative, and Natural Killer-Inducing Activities. Journal of Interferon Research. 12(1). 55–59. 101 indexed citations

20.

Glaspy, John A., et al.. (1992). Treatment of Hairy Cell Leukemia with Granulocyte Colony-Stimulating Factor and Recombinant Consensus Interferon or Recombinant Interferon-Alpha-2b. Journal of Immunotherapy. 11(3). 198–208. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact